Gossamer Bio
GOSS
78 hedge funds and large institutions have $694M invested in Gossamer Bio in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 40 increasing their positions, 14 reducing their positions, and 7 closing their positions.
397% more capital inflows, than outflows
Capital inflows: $238M | Capital outflows: $47.8M
186% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 14
71% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 7
28% more call options, than puts
Call options by funds: $20M | Put options by funds: $15.7M
7.02% more ownership
Funds ownership: 55.68% → 62.7% (+7%)
5% more funds holding
Funds holding: 74 → 78 (+4)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$98.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.2M |
| 3 |
BlackRock
New York
|
+$30M |
| 4 |
State Street
Boston,
Massachusetts
|
+$7.96M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$6.54M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EcoR1 Capital
San Francisco,
California
|
-$15.4M |
| 2 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$7.96M |
| 3 |
Baupost Group
Boston,
Massachusetts
|
-$5.97M |
| 4 |
Marshall Wace North America
New York
|
-$5.77M |
| 5 |
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$3.18M |
GOSS Hedge Fund Activity: Q3 2019 in Review
78 of the 4,576 institutional investors tracked by Wall St. Rank reported a position in Gossamer Bio (GOSS) for Q3 2019, worth a combined $694M — down 15% from $813M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new GOSS positions and 7 closed out — a net gain of 5 holders — while 40 added to existing stakes and 14 trimmed.
The largest buyer was HHLR Advisors, adding an estimated $98.9M. The largest seller was EcoR1 Capital, exiting entirely with an estimated $15.4M sold.
- 78 institutional investors held Gossamer Bio (GOSS) as of Q3 2019, up from 74 in Q2 2019.
- Funds reported $694M of Gossamer Bio stock for Q3 2019, down 15% quarter-over-quarter.
- 12 funds opened new Gossamer Bio positions in Q3 2019 and 7 closed out, a net change of +5 holders.
- The largest Gossamer Bio buyer in Q3 2019 was HHLR Advisors, an estimated $98.9M added.
- The largest Gossamer Bio seller in Q3 2019 was EcoR1 Capital, an estimated $15.4M sold.
Based on aggregated 13F filings for Q3 2019.